SunTrust Starts Catalyst Pharmaceutical Partners (CPRX) at Buy
Get Alerts CPRX Hot Sheet
Price: $14.68 -2.91%
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
SunTrust Robinson Humphrey initiated coverage on Catalyst Pharmaceutical Partners (NASDAQ: CPRX) with a Buy rating and a price target of $7.00.
For an analyst ratings summary and ratings history on Catalyst Pharmaceutical Partners click here. For more ratings news on Catalyst Pharmaceutical Partners click here.
Shares of Catalyst Pharmaceutical Partners closed at $3.73 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May
- Craig-Hallum Assumes DiaMedica Therapeutics Inc. (DMAC) at Buy
- Morgan Stanley Assumes Harley-Davidson (HOG) at Overweight, 'Freshly Tuned Up with Open Road Ahead'
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
SunTrust Robinson HumphreySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!